How to buy USANA Health Sciences stock | 75.09

USANA Health Sciences, Inc is a household & personal products business based in the US. USANA Health Sciences shares (USNA) are listed on the NYSE and all prices are listed in US Dollars. USANA Health Sciences employs 1,909 staff and has a trailing 12-month revenue of around USD$1.1 billion.

How to buy shares in USANA Health Sciences

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for USANA Health Sciences. Find the stock by name or ticker symbol: USNA. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until USANA Health Sciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$75.09, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of USANA Health Sciences, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of USANA Health Sciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

USANA Health Sciences share price

Use our graph to track the performance of USNA stocks over time.

USANA Health Sciences shares at a glance

• Key figures

Information last updated 2020-11-26.

Latest market close	USD$75.09
52-week range	USD$43.01 - USD$92.26
50-day moving average	USD$77.7236
200-day moving average	USD$79.5285
Wall St. target price	USD$100
PE ratio	14.0833
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$5.421

Buy USANA Health Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy USANA Health Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of USANA Health Sciences, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

USANA Health Sciences price performance over time

Historical closes compared with the close of $75.09 from 2020-11-16

1 week (2020-11-16)	N/A
1 month (2020-10-23)	N/A
3 months (2020-08-23)	N/A
6 months (2020-05-23)	N/A

1 year (2019-11-23)	N/A
2 years (2018-11-23)	N/A
3 years (2017-11-23)	N/A
5 years (2015-11-23)	N/A

Is USANA Health Sciences under- or over-valued?

Valuing USANA Health Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of USANA Health Sciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

USANA Health Sciences's P/E ratio

USANA Health Sciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, USANA Health Sciences shares trade at around 14x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

USANA Health Sciences's PEG ratio

USANA Health Sciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.63. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into USANA Health Sciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

USANA Health Sciences's EBITDA

USANA Health Sciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$182.6 million.

The EBITDA is a measure of a USANA Health Sciences's overall financial performance and is widely used to measure a its profitability.

USANA Health Sciences financials

Revenue TTM	USD$1.1 billion
Operating margin TTM	15.38%
Gross profit TTM	USD$873.4 million
Return on assets TTM	20.24%
Return on equity TTM	32.92%
Profit margin	10.57%
Book value	$18.512
Market capitalisation	USD$1.6 billion

TTM: trailing 12 months

Shorting USANA Health Sciences shares

There are currently 814,650 USANA Health Sciences shares held short by investors – that's known as USANA Health Sciences's "short interest". This figure is 17.1% down from 982,169 last month.

There are a few different ways that this level of interest in shorting USANA Health Sciences shares can be evaluated.

USANA Health Sciences's "short interest ratio" (SIR)

USANA Health Sciences's "short interest ratio" (SIR) is the quantity of USANA Health Sciences shares currently shorted divided by the average quantity of USANA Health Sciences shares traded daily (recently around 115553.19148936). USANA Health Sciences's SIR currently stands at 7.05. In other words for every 100,000 USANA Health Sciences shares traded daily on the market, roughly 7050 shares are currently held short.

However USANA Health Sciences's short interest can also be evaluated against the total number of USANA Health Sciences shares, or, against the total number of tradable USANA Health Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case USANA Health Sciences's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 USANA Health Sciences shares in existence, roughly 40 shares are currently held short) or 0.0723% of the tradable shares (for every 100,000 tradable USANA Health Sciences shares, roughly 72 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against USANA Health Sciences.

Find out more about how you can short USANA Health Sciences stock.

USANA Health Sciences share dividends

We're not expecting USANA Health Sciences to pay a dividend over the next 12 months.

Have USANA Health Sciences's shares ever split?

USANA Health Sciences's shares were split on a 2:1 basis on 23 November 2016. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your USANA Health Sciences shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for USANA Health Sciences shares which in turn could have impacted USANA Health Sciences's share price.

USANA Health Sciences share price volatility

Over the last 12 months, USANA Health Sciences's shares have ranged in value from as little as $43.01 up to $92.26. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while USANA Health Sciences's is 1.1003. This would suggest that USANA Health Sciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

USANA Health Sciences overview

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Frequently asked questions

• What percentage of USANA Health Sciences is owned by insiders or institutions?

  Currently 40.439% of USANA Health Sciences shares are held by insiders and 57.607% by institutions.

• How many people work for USANA Health Sciences?

  Latest data suggests 1,909 work at USANA Health Sciences.

• When does the fiscal year end for USANA Health Sciences?

  USANA Health Sciences's fiscal year ends in December.

• Where is USANA Health Sciences based?

  USANA Health Sciences's address is: 3838 West Parkway Boulevard, Salt Lake City, UT, United States, 84120

• What is USANA Health Sciences's ISIN number?

  USANA Health Sciences's international securities identification number is: US90328M1071

• What is USANA Health Sciences's CUSIP number?

  USANA Health Sciences's Committee on Uniform Securities Identification Procedures number is: 90328M107